title: Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation.
abstract: OBJECTIVE
  To investigate a case of a young woman with both primary antiphospholipid syndrome and factor V Leiden mutation who developed multiple retinal arteriolar occlusions.
  
  
  METHODS
  Case report of a 25-year-old woman with history and laboratory tests confirming the diagnosis of both primary antiphospholipid syndrome and factor V Leiden mutation who presented with blurred vision in both eyes.
  
  
  RESULTS
  Multiple retinal arteriolar occlusions were observed in both of her eyes. The patient was treated first with heparin and then with warfarin.
  
  
  CONCLUSIONS
  Primary antiphospholipid syndrome and factor V Leiden mutation, as well as other forms of thrombophilia, should be considered in the differential diagnosis of unexplained retinal vascular occlusions. The coexistence of several thrombophilic disorders may carry a particularly high risk for thrombotic manifestations.
authors.affiliation: Department of Ophthalmology, Rambam Medical Center, Haifa, Israel. i.pastal@rambam.health.gov.il
authors.forename: D
authors.initials: D
authors.lastname: Dori
authors.forename: I
authors.initials: I
authors.lastname: Beiran
authors.forename: Y
authors.initials: Y
authors.lastname: Gelfand
authors.forename: N
authors.initials: N
authors.lastname: Lanir
authors.forename: J
authors.initials: J
authors.lastname: Scharf
authors.forename: B
authors.initials: B
authors.lastname: Miller
authors.forename: B
authors.initials: B
authors.lastname: Brenner
mesh_terms: D020016:Activated Protein C Resistance / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D000328:Adult; D016736:Antiphospholipid Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D001160:Arterioles / Q000473:pathology; D005165:Factor V / Q000235:genetics*; D005260:Female; D005451:Fluorescein Angiography; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D017354:Point Mutation; D015356:Retinal Artery Occlusion / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D014859:Warfarin / Q000627:therapeutic use
chemical_list: C095381:factor V Leiden; D014859:Warfarin; D005165:Factor V; D006493:Heparin